Contribution of dynamic contrast MR imaging to the differentiation between dural metastasis and meningioma.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMID 15232661)

Published in Neuroradiology on June 30, 2004

Authors

S Kremer1, S Grand, C Rémy, B Pasquier, A L Benabid, S Bracard, J F Le Bas

Author Affiliations

1: Neuroradiology Department, University Hospital, Nancy, France. kremers@club-internet.fr

Articles citing this

Quantitative imaging biomarkers in neuro-oncology. Nat Rev Clin Oncol (2009) 1.28

Imaging of cerebellopontine angle lesions: an update. Part 1: enhancing extra-axial lesions. Eur Radiol (2007) 0.97

Metastatic disease of the brain: extra-axial metastases (skull, dura, leptomeningeal) and tumour spread. Eur Radiol (2004) 0.96

Contribution of perfusion-weighted magnetic resonance imaging in the differentiation of meningiomas and other extra-axial tumors: case reports and literature review. J Neurooncol (2011) 0.90

Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation? Neuroradiology (2006) 0.89

Metastatic breast carcinoma mimicking basal skull meningioma. Clin Ophthalmol (2007) 0.83

Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesions. Exp Ther Med (2014) 0.81

Pediatric microcystic meningioma: a clinical, histological, and radiographic case-based review. Childs Nerv Syst (2012) 0.81

Imaging of skull base pathologies: Role of advanced magnetic resonance imaging techniques. Neuroradiol J (2015) 0.79

Intraparenchymal hemorrhage from dural metastasis of breast cancer mimicking meningioma. Neuroradiol J (2016) 0.75

Intracranial extramedullary hematopoiesis in beta-thalassemia. Korean J Radiol (2012) 0.75

Usefulness of 320-row area detector computed tomography for the diagnosis of cystic falx meningioma. Case Rep Oncol (2013) 0.75

Intracranial Rosai-Dorfman disease mimicking multiple meningiomas in a child: a case report and review of the literature. Childs Nerv Syst (2014) 0.75

Articles cited by this

Perfusion imaging with NMR contrast agents. Magn Reson Med (1990) 5.01

Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology (2002) 2.41

Typical, atypical, and misleading features in meningioma. Radiographics (1991) 2.14

Methodology of brain perfusion imaging. J Magn Reson Imaging (2001) 1.99

MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis. Magn Reson Med (2001) 1.68

Intracranial metastasis or meningioma? An uncommon clinical diagnostic dilemma. Surg Neurol (2002) 1.54

Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol (2002) 1.53

Dural lesions mimicking meningiomas. Hum Pathol (2002) 1.45

Metastatic tumors of the brain: a follow-up study of 195 patients with neurosurgical considerations. J Neurosurg (1960) 1.02

Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging. J Magn Reson Imaging (1997) 1.02

Dural "tail" associated with meningiomas on Gd-DTPA-enhanced MR images: characteristics, differential diagnostic value, and possible implications for treatment. Radiology (1990) 1.01

Thickening of dura surrounding meningiomas: MR features. J Comput Assist Tomogr (1989) 0.99

Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett (2003) 0.97

Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol (2002) 0.95

Metastatic brain tumors with dural extension. J Neurosurg (1998) 0.92

Vascularity of meningiomas and neuromas: assessment with dynamic susceptibility-contrast MR imaging. AJR Am J Roentgenol (1994) 0.92

Prominent dural enhancement adjacent to nonmeningiomatous malignant lesions on contrast-enhanced MR images. AJNR Am J Neuroradiol (1991) 0.89

Prominent meningeal enhancement adjacent to meningioma on Gd-DTPA-enhanced MR images: histopathologic correlation. Radiology (1990) 0.88

Intracranial meningioma. AJNR Am J Neuroradiol (1992) 0.84

Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases. Neuroradiology (2002) 0.84

Pathologic significance of meningeal enhancement ("flare sign") of meningiomas on MRI. Surg Neurol (1997) 0.83

Meningeal metastasis of the cerebellopontine angle demonstrating "dural tail" sign. Can Assoc Radiol J (1994) 0.78

[Dural metastases mimicking meningioma. Report of a case]. Neurochirurgie (1999) 0.78

Articles by these authors

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (1998) 4.72

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet (1995) 3.06

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol (2001) 2.45

Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology (2006) 2.28

Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis. Neurology (2011) 2.27

The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology (2002) 2.14

Coexistence of plasma cell granulomas of lung and central nervous system. Pathol Res Pract (1995) 2.13

Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 1.88

Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology (2000) 1.85

The impact of deep brain stimulation on executive function in Parkinson's disease. Brain (2000) 1.74

Extraneural metastases of astrocytomas and glioblastomas: clinicopathological study of two cases and review of literature. Cancer (1980) 1.71

Solitary fibrous tumour of the liver with CD34 expression. Histopathology (1996) 1.69

[An exceptional variety of medulloblastoma: melanotic medulloblastoma]. Ann Pathol (1997) 1.65

Intracranial aneurysms: clinical value of 3D digital subtraction angiography in the therapeutic decision and endovascular treatment. Radiology (2001) 1.65

Percutaneous intradiscal radio-frequency thermocoagulation. A cadaveric study. Spine (Phila Pa 1976) (1995) 1.62

Endovascular treatment of intracranial aneurysms with matrix detachable coils: midterm anatomic follow-up from a prospective multicenter registry. AJNR Am J Neuroradiol (2007) 1.59

Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol (1999) 1.57

Risk of stroke and recurrent dissection after a cervical artery dissection: a multicenter study. Neurology (2003) 1.56

Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain (1998) 1.56

Endovascular treatment of intracranial aneurysms with matrix detachable coils: immediate posttreatment results from a prospective multicenter registry. AJNR Am J Neuroradiol (2006) 1.54

Systemic granulomatous reaction to a foreign body after hip replacement. N Engl J Med (1996) 1.50

Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol (1997) 1.48

The core assessment program for intracerebral transplantation. Mov Disord (1995) 1.47

Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci Lett (1995) 1.43

Inhibition of levodopa effects by internal pallidal stimulation. Mov Disord (1998) 1.42

Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience (2000) 1.41

[Effects of the stimulation of the subthalamic nucleus in Parkinson disease]. Rev Neurol (Paris) (1993) 1.39

Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology (2001) 1.39

[Recommendations for the use of intravenous thrombolytic therapy in cerebrovascular ischemic accident. French Society of Neurovascular Disorders]. Rev Neurol (Paris) (2000) 1.39

Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites. Cancer Res (2001) 1.34

Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke (1999) 1.34

Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord (1995) 1.28

Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord (2001) 1.27

Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol (2002) 1.25

Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J (1992) 1.24

Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol (1998) 1.23

Central neurocytomas. Critical evaluation of a small-cell neuronal tumor. Am J Surg Pathol (1992) 1.22

In vivo assessment of tumoral angiogenesis. Magn Reson Med (2004) 1.22

Acute spontaneous hemorrhage after embolization of brain arteriovenous malformation with N-butyl cyanoacrylate. J Neuroradiol (2001) 1.21

Deep brain stimulation in the treatment of severe dystonia. J Neurol (2001) 1.19

Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov Disord (1998) 1.17

A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: nosologic images. Nat Med (2000) 1.17

Subcutaneous apomorphine in Parkinson's disease. J Neurol Neurosurg Psychiatry (1989) 1.16

Persistent carotid-vertebrobasilar anastomoses: how and why differentiating them? J Neuroradiol (2004) 1.13

EGF receptor amplification and expression in human brain tumours. Eur J Cancer (1992) 1.12

Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir (Wien) (1995) 1.11

[Cerebral ischemic accidents in young subjects. A prospective study of 296 patients aged 16 to 45 years]. Rev Neurol (Paris) (1999) 1.10

Papillary meningioma. Clinicopathologic study of seven cases and review of the literature. Cancer (1986) 1.10

Mucoceles of the sphenoidal sinus. Report of six cases and review of the literature. J Neuroradiol (1990) 1.09

Diffuse lesions in the CNS revealed by MR imaging in a case of Whipple disease. AJNR Am J Neuroradiol (2001) 1.09

Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov Disord (1996) 1.08

Aneurysm clipping after endovascular treatment with coils: a report of eight patients. Neurosurgery (1996) 1.08

Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian voice. Brain Lang (2001) 1.08

Effect of stimulation of the subthalamic nucleus on oral control of patients with parkinsonism. J Neurol Neurosurg Psychiatry (1999) 1.07

Role of the hypothalamic hamartoma in the genesis of gelastic fits (a video-stereo-EEG study). Electroencephalogr Clin Neurophysiol (1995) 1.06

Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease. Lancet (1997) 1.05

From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity. Brain (1999) 1.05

Time-course of changes in firing rates and firing patterns of subthalamic nucleus neuronal activity after 6-OHDA-induced dopamine depletion in rats. Brain Res (2001) 1.05

Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. Eur J Neurosci (1996) 1.04

Immunohistochemical expression of WT1 by desmoplastic small round cell tumor: a comparative study with other small round cell tumors. Am J Surg Pathol (2000) 1.04

High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. Cancer Res (2001) 1.04

Subthalamic stimulation for Parkinson's disease. Arch Med Res (2000) 1.04

Digestion and absorption of 2 fat emulsions with different droplet sizes in the human digestive tract. Am J Clin Nutr (1999) 1.04

Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease. Lancet (1997) 1.03

Thalamic stimulation and suppression of parkinsonian tremor. Evidence of a cerebellar deactivation using positron emission tomography. Brain (1993) 1.03

Functional MRI of the human brain: predominance of signals from extracerebral veins. Neuroreport (1994) 1.01

Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am J Physiol (1996) 1.00

Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat. Exp Neurol (2006) 1.00

Venous territories of the brain. J Neuroradiol (1994) 0.99

Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology (2002) 0.98

Changes in the firing pattern of globus pallidus neurons after the degeneration of nigrostriatal pathway are mediated by the subthalamic nucleus in the rat. Eur J Neurosci (2000) 0.98

[Subcutaneous administration of apomorphine in motor fluctuations in Parkinson's disease]. Rev Neurol (Paris) (1990) 0.98

A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes. J Immunol (2001) 0.98

Gait is associated with an increase in tonic firing of the sub-cuneiform nucleus neurons. Neuroscience (2008) 0.98

Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study. Eur J Cancer (2006) 0.97

Computer-driven robot for stereotactic surgery connected to CT scan and magnetic resonance imaging. Technological design and preliminary results. Appl Neurophysiol (1987) 0.97

MR spectroscopy of bilateral thalamic gliomas. AJNR Am J Neuroradiol (1999) 0.97

Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease. Neurology (2000) 0.97

Simultaneous recording of spontaneous activities and nociceptive responses from neurons in the pars compacta of substantia nigra and in the lateral habenula. Eur J Neurosci (1996) 0.96

Intracranial plasma cell granuloma: a report of four cases. Surg Neurol (1994) 0.96

Long-term effects of chronic stimulation of the ventral intermediate thalamic nucleus in different types of tremor. Adv Neurol (1993) 0.96

Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease. Ann Neurol (1999) 0.96

Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection. Br J Cancer (2003) 0.96

Microvascularization of the intracranial dura mater. Surg Radiol Anat (1987) 0.95

CD34 positivity in solitary fibrous tumor of the liver. Am J Surg Pathol (1995) 0.95

Dural fistulae of the tentorium cerebelli. Radioanatomical, clinical and therapeutic considerations. J Neuroradiol (1990) 0.95

Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol (2002) 0.95

Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas. Int J Cancer (1994) 0.95